POLYMEDICA CORP
10-Q, EX-27.1, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: POLYMEDICA CORP, 10-Q, EX-10.73, 2000-11-14
Next: AMERICAN MORTGAGE INVESTORS TRUST, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          MAR-31-2001
<PERIOD-START>                             APR-01-2000
<PERIOD-END>                               SEP-30-2000
<EXCHANGE-RATE>                                      1
<CASH>                                          20,262
<SECURITIES>                                    20,300
<RECEIVABLES>                                   44,492
<ALLOWANCES>                                    12,045
<INVENTORY>                                      7,682
<CURRENT-ASSETS>                                98,346
<PP&E>                                          25,583
<DEPRECIATION>                                   4,970
<TOTAL-ASSETS>                                 191,562
<CURRENT-LIABILITIES>                           24,261
<BONDS>                                          2,547
                                0
                                          0
<COMMON>                                           132
<OTHER-SE>                                     149,629
<TOTAL-LIABILITY-AND-EQUITY>                   191,562
<SALES>                                        105,639
<TOTAL-REVENUES>                               105,639
<CGS>                                           38,338
<TOTAL-COSTS>                                   38,338
<OTHER-EXPENSES>                                46,733
<LOSS-PROVISION>                                 7,833
<INTEREST-EXPENSE>                                 148
<INCOME-PRETAX>                                 21,512
<INCOME-TAX>                                     8,024
<INCOME-CONTINUING>                             13,488
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    13,488
<EPS-BASIC>                                       1.03
<EPS-DILUTED>                                      .99


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission